发明名称 |
Migrastatin analogs in the treatment of cancer |
摘要 |
In one aspect, the present invention provides a method for treating colon and/or ovarian cancer in a subject comprising administering to a subject in need thereof a compound of general formula (I): wherein R1-R6, R, -R, Q, Y1, Y2 and n are as defined herein, wherein the compound is present in an amount effective to inhibit colon and/or ovarian tumor metastasis.; |
申请公布号 |
US8957056(B2) |
申请公布日期 |
2015.02.17 |
申请号 |
US200511597678 |
申请日期 |
2005.05.25 |
申请人 |
Sloan-Kettering Instiute for Cancer Research |
发明人 |
Danishefsky Samuel J.;Gaul Christoph;Njardarson Jón T.;Moore Malcolm A. S.;Wu Kaida;Dorn David C.;Mandal Mihirbaran |
分类号 |
A61K31/395;A61K31/335;C07D313/00;C07D225/02;A61K31/365;A61K31/435 |
主分类号 |
A61K31/395 |
代理机构 |
Choate, Hall & Stewart, LLP |
代理人 |
Choate, Hall & Stewart, LLP ;Jarrell Brenda Herschbach;Rearick John P. |
主权项 |
1. A method for treating ovarian cancer in a subject comprising administering to a subject in need thereof a therapeutically effective amount of a compound having the structure: or pharmaceutically acceptable salt thereof; wherein R1 and R2 are each hydrogen; R3 is hydrogen or methyl; R4 is —OH, OAc, NH2, or F, or R4 taken together with the carbon atom to which it is attached forms a moiety having the structure: R5 is hydrogen or methyl; R6 is hydrogen or methyl; Ra and Rb are hydrogen; Rc is hydrogen; n is 3; X1 is O, NRX1 or CRX1RX2; wherein RX1 and RX2 are hydrogen; Q is hydrogen; and Y1 and Y2 are hydrogen, or Y1 and Y2 together with the carbon atom to which they are attached form a moiety having the structure: wherein the compound is administered at a dosage from about 1 mg/kg to about 70 mg/kg, or wherein the compound is administered at a dosage of about 70 mg/kg or greater; and wherein the compound is present in an amount effective to inhibit ovarian tumor metastasis. |
地址 |
New York NY US |